Osteopontin (Eta-1) and Fibroblast Growth Factor-2 Cross-Talk in Angiogenesis
- 15 July 2003
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 171 (2) , 1085-1093
Abstract
The cytokine/extracellular matrix protein osteopontin (OPN/Eta-1) is an important component of cellular immunity and inflammation. It also acts as a survival, cell-adhesive, and chemotactic factor for endothelial cells. Here, subtractive suppression hybridization showed that serum-deprived murine aortic endothelial (MAE) cells transfected with the angiogenic fibroblast growth factor-2 (FGF2) overexpress OPN compared with parental cells. This was confirmed by Northern blotting and Western blot analysis of the conditioned media in different clones of endothelial cells overexpressing FGF2 and in endothelial cells treated with the recombinant growth factor. In vivo, FGF2 caused OPN expression in newly formed endothelium of the chick embryo chorioallantoic membrane (CAM) and of murine s.c. Matrigel plug implants. Recombinant OPN (rOPN), the fusion protein GST-OPN, and the deletion mutant GST-ΔRGD-OPN were angiogenic in the CAM assay. Angiogenesis was also triggered by OPN-transfected MAE cells grafted onto the CAM. OPN-driven neovascularization was independent from endothelial αvβ3 integrin engagement and was always paralleled by the appearance of a massive mononuclear cell infiltrate. Accordingly, rOPN, GST-OPN, GST-ΔRGD-OPN, and the conditioned medium of OPN-overexpressing MAE cells were chemotactic for isolated human monocytes. Also, rOPN triggered a proangiogenic phenotype in human monocytes by inducing the expression of the angiogenic cytokines TNF-α and IL-8. OPN-mediated recruitment of proangiogenic monocytes may represent a mechanism of amplification of FGF2-induced neovascularization during inflammation, wound healing, and tumor growth.Keywords
This publication has 52 references indexed in Scilit:
- Gene expression profile in fibroblast growth factor 2-transformed endothelial cellsOncogene, 2002
- Altered wound healing in mice lacking a functional osteopontin gene (spp1).Journal of Clinical Investigation, 1998
- Differential Expression of Osteopontin, PC4, and CEC5, a Novel mRNA Species, duringin VitroAngiogenesisExperimental Cell Research, 1998
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisCell, 1996
- Interleukin 6 Induces the Expression of Vascular Endothelial Growth FactorJournal of Biological Chemistry, 1996
- Glucocorticoids Increase Osteopontin Expression in Cardiac Myocytes and Microvascular Endothelial CellsJournal of Biological Chemistry, 1995
- Site‐directed mutagenesis of the arginine‐glycine‐aspartic acid sequence in osteopontin destroys cell adhesion and migration functionsJournal of Cellular Biochemistry, 1995
- Cyclic AMP distinguishes between two functions of acidic FGF in a rat bladder carcinoma cell line.Journal of Cell Biology, 1993
- Nuclear localization of endogenous basic fibroblast growth factor in cultured endothelial cellsExperimental Cell Research, 1991
- Immunoreactive fibroblast growth factor in cells of peritoneal exudate suggests its identity with macrophage-derived growth factorBiochemical and Biophysical Research Communications, 1985